Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Hisamitsu Pharmaceutical Shareholders Equity (Quarterly): 1.758B for Feb. 29, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 1.758B |
November 30, 2023 | 1.830B |
August 31, 2023 | 1.867B |
May 31, 2023 | 1.856B |
February 28, 2023 | 1.880B |
November 30, 2022 | 1.944B |
August 31, 2022 | 1.905B |
May 31, 2022 | 1.955B |
February 28, 2022 | 2.190B |
November 30, 2021 | 2.216B |
August 31, 2021 | 2.355B |
May 31, 2021 | 2.319B |
February 28, 2021 | 2.367B |
November 30, 2020 | 2.395B |
August 31, 2020 | 2.382B |
May 31, 2020 | 2.303B |
February 29, 2020 | 2.306B |
November 30, 2019 | 2.272B |
August 31, 2019 | 2.290B |
May 31, 2019 | 2.208B |
February 28, 2019 | 2.231B |
November 30, 2018 | 2.211B |
August 31, 2018 | 2.241B |
May 31, 2018 | 2.219B |
February 28, 2018 | 2.270B |
Date | Value |
---|---|
November 30, 2017 | 2.146B |
August 31, 2017 | 2.115B |
May 31, 2017 | 2.052B |
February 28, 2017 | 2.023B |
November 30, 2016 | 1.929B |
August 31, 2016 | 2.148B |
May 31, 2016 | 2.035B |
February 29, 2016 | 1.979B |
November 30, 2015 | 1.856B |
August 31, 2015 | 1.896B |
May 31, 2015 | 1.804B |
February 28, 2015 | 1.851B |
November 30, 2014 | 1.769B |
August 31, 2014 | 1.944B |
May 31, 2014 | 1.917B |
February 28, 2014 | 1.914B |
November 30, 2013 | 1.854B |
August 31, 2013 | 1.887B |
May 31, 2013 | 1.755B |
February 28, 2013 | 1.811B |
November 30, 2012 | 1.911B |
August 31, 2012 | 1.970B |
May 31, 2012 | 1.897B |
February 29, 2012 | 1.841B |
November 30, 2011 | 1.818B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.758B
Minimum
Feb 2024
2.395B
Maximum
Nov 2020
2.126B
Average
2.216B
Median
Nov 2021
Shareholders Equity (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 48.05B |
Nxera Pharma Co Ltd | 435.31M |
PeptiDream Inc | 264.18M |
Healios KK | 24.45M |
AnGes Inc | 165.52M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.182B |
Total Liabilities (Quarterly) | 409.58M |
Debt to Equity Ratio | 0.0043 |
Current Ratio | 4.224 |
Net Debt Paydown Yield | 0.01% |